0001567619-22-013787.txt : 20220707
0001567619-22-013787.hdr.sgml : 20220707
20220707161716
ACCESSION NUMBER: 0001567619-22-013787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220705
FILED AS OF DATE: 20220707
DATE AS OF CHANGE: 20220707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GHALIE RICHARD G
CENTRAL INDEX KEY: 0001156208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50484
FILM NUMBER: 221071837
MAIL ADDRESS:
STREET 1: C/O FAVRILLE, INC
STREET 2: 10445 PACIFIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEI Pharma, Inc.
CENTRAL INDEX KEY: 0001262104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510407811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-369-7100
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MARSHALL EDWARDS INC
DATE OF NAME CHANGE: 20030902
4
1
doc1.xml
FORM 4
X0306
4
2022-07-05
0
0001262104
MEI Pharma, Inc.
MEIP
0001156208
GHALIE RICHARD G
C/O MEI PHARMA, INC.
11455 EL CAMINO REAL, SUITE 250
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Common Stock
2022-07-05
4
F
0
8196
0.54
D
28927
D
Stock Option (Right to Buy)
0.54
2022-07-05
4
A
0
560000
0.00
A
2032-07-05
Common Stock
560000
560000
D
Stock Option (Right to Buy)
2.95
2031-07-01
Common Stock
320000
320000
D
Stock Option (Right to Buy)
1.21
2026-03-07
Common Stock
130000
130000
D
Stock Option (Right to Buy)
1.38
2026-07-14
Common Stock
25000
25000
D
Stock Option (Right to Buy)
2.88
2027-07-07
Common Stock
65000
65000
D
Stock Option (Right to Buy)
4.28
2028-07-12
Common Stock
130000
130000
D
Stock Option (Right to Buy)
2.52
2029-07-01
Common Stock
150000
150000
D
Stock Option (Right to Buy)
3.49
2030-07-02
Common Stock
150000
150000
D
Stock Option (Right to Buy)
3.55
2031-05-03
Common Stock
75000
75000
D
Represents the number of shares withheld by and surrendered to the Issuer on July 5, 2022, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
One-quarter of such options vested on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
All options are currently exercisable.
One-quarter of such options vested on July 12, 2019, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
One-quarter of such options vested on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022.
/s/ Brian G. Drazba, as attorney in fact
2022-07-07